SINGAPORE, July 28, 2021 – Family cord blood bank, Cryoviva Singapore has announced that it has made a successful foray into the UAE market in line with its strategic growth plans. After 7 years of operations and serving young families in Singapore, the expansion into Dubai and the other Emirates in the UAE is an important milestone for Cryoviva.
“This is indeed an important step in our journey to fulfill our mission to give every family the chance to benefit from the medical potential of cord component stem cells should they ever need it. That we have been able to attract young families in the UAE to trust us with their baby’s precious cord blood is not only a testament to our credentials as a company but also to Singapore’s reputation for world-class facilities and strict adherence to high quality standards. We invite healthcare providers offering maternity services to collaborate with us to provide even greater service to their valued patients,” said Rajesh Nair, CEO of Cryoviva Singapore.
“While we continue with our growth efforts in several other countries- both in the ASEAN region as well as in the Middle East- I’d also like to reiterate our commitment to serving families in Singapore. We believe that there is still considerable potential for family cord blood banking services to grow in a developed and discerning market like Singapore. We also look forward to contributing our bit to furthering our city’s position as a great destination to avail of world-class healthcare services.”